Literature DB >> 9135465

Chest high resolution CT in adults with primary humoral immunodeficiency.

A Feydy1, J Sibilia, E De Kerviler, A M Zagdanski, S Chevret, J P Fermand, J C Brouet, J Frija.   

Abstract

The purpose of this study was to assess the findings on chest high resolution computed tomography (HRCT) in patients with primary humoral immunodeficiency. HRCT was prospectively and consecutively performed in 19 patients with primary humoral immunodeficiency, aged 15-64 years (mean 36), and in 15 healthy subjects. HRCT results were correlated with clinical and biological data. Bronchial lesions were observed in 11 patients (58%), consisting either of bronchial wall thickening in eight or bronchiectasis in eight; both were present in five patients. Lobar and/or segmental collapses were found in seven patients (37%), scars in eight patients (42%), interstitial lesions in six patients (32%), and lobular air-trapping in two patients (11%). Parenchymal collapses were correlated with the annual frequency of infections (p = 0.03) and with the IgA level (p = 0.01). Scars were correlated with the annual frequency of infections (p = 0.04). No correlation was found between bronchial wall thickening or bronchiectasis and the data analysed. In conclusion, HRCT is a useful method to demonstrate lung disease in primary humoral immunodeficiencies, with special emphasis on bronchial changes and interstitial lesions.

Entities:  

Mesh:

Year:  1996        PMID: 9135465     DOI: 10.1259/0007-1285-69-828-1108

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.

Authors:  A A J M van de Ven; P A de Jong; D P Hoytema van Konijnenburg; O A M Kessels; M Boes; E A M Sanders; S W J Terheggen-Lagro; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

2.  Respiratory Complications in Patients with Hyper IgM Syndrome.

Authors:  Bobak Moazzami; Reza Yazdani; Gholamreza Azizi; Fatemeh Kiaei; Mitra Tafakori; Mohammadreza Modaresi; Rohola Shirzadi; Seyed Alireza Mahdaviani; Mahsa Sohani; Hassan Abolhassani; Asghar Aghamohammadi
Journal:  J Clin Immunol       Date:  2019-06-11       Impact factor: 8.317

3.  Evaluation of pulmonary findings in patients with humoral immunodeficiency.

Authors:  Zuhal Karalı; Yasin Karalı; Şükrü Çekiç; Zeynep Yazıcı; Yakup Canıtez; Nihat Sapan; Sara Şebnem Kılıç Gültekin
Journal:  Turk Pediatri Ars       Date:  2020-06-19

Review 4.  Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.

Authors:  P Wood; S Stanworth; J Burton; A Jones; D G Peckham; T Green; C Hyde; H Chapel
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 5.  Clinical immunology review series: An approach to the management of pulmonary disease in primary antibody deficiency.

Authors:  M D Tarzi; S Grigoriadou; S B Carr; L M Kuitert; H J Longhurst
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

Review 6.  Pulmonary manifestations of primary immunodeficiency disorders in children.

Authors:  Milos Jesenak; Peter Banovcin; Barbora Jesenakova; Eva Babusikova
Journal:  Front Pediatr       Date:  2014-07-25       Impact factor: 3.418

7.  Chest CT Manifestations in Children with CVID: A 10-Year Report.

Authors:  Mohammad Reza Boloursaz; Soheila Khalilzadeh; Pegah Rahmati Nezhad; Mehrdad Bakhshayesh Karam; Alireza Mahdaviani; Leila Mosadegh; Maryam Hassanzad; Seyed Mohsen Mir Hosseini
Journal:  Tanaffos       Date:  2012
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.